Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$5.8M |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$131M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Joyce Meghan V. | Nov 13, 2024 | Sell | 2,896 | $29.9017 | $87,000 |
| CLARK IAN T | Nov 12, 2024 | Sell | 7,242 | $29.4351 | $210,000 |
| CLARK IAN T | Nov 12, 2024 | Sell | 1,076 | $29.5172 | $32,000 |
| Joyce Meghan V. | Jun 4, 2024 | Sell | 100 | $27.87 | $2,800 |
| Kalia Kumud | Mar 18, 2024 | Buy | 2,187 | $17.8156 | $39,000 |
| Joyce Meghan V. | Mar 4, 2024 | Sell | 100 | $19.05 | $1,900 |
| Joyce Meghan V. | Dec 4, 2023 | Sell | 100 | $26.34 | $2,600 |
| Kalia Kumud | Dec 1, 2023 | Sell | 5,800 | $26.3714 | $150,000 |
| Kalia Kumud | Sep 12, 2023 | Sell | 2,125 | $32.59 | $69,000 |
| Joyce Meghan V. | Sep 5, 2023 | Sell | 100 | $35.01 | $3,500 |
| Joyce Meghan V. | Jun 15, 2023 | Sell | 2,766 | $37.55 | $100,000 |
| Kalia Kumud | Jun 9, 2023 | Buy | 2,231 | $32.6821 | $73,000 |
| Kalia Kumud | Jun 9, 2023 | Buy | 750 | $32.779 | $25,000 |
| Eltoukhy Helmy | Mar 15, 2023 | Buy | 8,600 | $26.1544 | $220,000 |
| Eltoukhy Helmy | Mar 14, 2023 | Buy | 84,452 | $26.3334 | $2.2M |
| Talasaz AmirAli | Mar 14, 2023 | Buy | 8,500 | $26.3972 | $220,000 |
| Talasaz AmirAli | Mar 14, 2023 | Buy | 4,250 | $26.3972 | $110,000 |
| Talasaz AmirAli | Mar 13, 2023 | Buy | 27,813 | $26.0392 | $720,000 |
| Talasaz AmirAli | Mar 13, 2023 | Buy | 13,906 | $26.0392 | $360,000 |
| Talasaz AmirAli | Mar 13, 2023 | Buy | 12,187 | $24.7795 | $300,000 |
| Talasaz AmirAli | Mar 13, 2023 | Buy | 6,094 | $24.7795 | $150,000 |
| Kalia Kumud | Mar 3, 2023 | Sell | 6,500 | $31.9179 | $210,000 |
What's the latest insider transaction for Guardant Health?
The most recent insider transaction for Guardant Health was conducted by Joyce Meghan V., who sold 2,896 shares on November 13, 2024 at a price of $29.90 per share.
Which insider bought the most GH stock over the last two years?
Eltoukhy Helmy has bought the most GH stock in the last 2 years, with a total value of $2.4M.
Which insider has sold the most GH stock over the last two years?
Kalia Kumud has sold the most GH stock in the last 2 years, with a total value of $430,000.
What is the total value of insider transactions for Guardant Health (GH) in the last 2 years?
According to our estimates, the total value of insider transactions for Guardant Health in the last 2 years is positive, amounting to $3.6M. This indicates that insiders have predominantly bought shares, showcasing their confidence in the company's future prospects.
How do insider transactions over the last 2 years reflect on Guardant Health's market confidence?
Over the last 2 years, insider transactions for Guardant Health have been balanced between buying and selling, showing a neutral stance among insiders towards the company's market performance. This trend of more purchases than sales could be a positive signal to potential investors about the insiders' view on the company's valuation and growth potential.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
